Home › Funds › MFS Investment Management › PTCT
MFS Investment Management position in PTCT
PTC THERAPEUTICS INC · Health Care
Latest position (Q2 2026)7.28K sh
Reported value held$594.07K
Portfolio Weight0.00%
First reportedQ3 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 44.77K | $1.66M | New |
| Q4 2024 | 43.48K | $1.96M | Reduce |
| Q1 2025 | 42.51K | $2.17M | Reduce |
| Q2 2025 | 43.04K | $2.10M | Add |
| Q3 2025 | 46.07K | $2.83M | Add |
| Q4 2025 | 44.59K | $3.39M | Reduce |
| Q1 2026 | 33.57K | $2.29M | Reduce |
| Q2 2026 | 7.28K | $594.07K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PTCT
- BlackRock Inc 13.96M sh · $1.14B · Q2 2026
- Vanguard Group 8.80M sh · $668.69M · Q4 2025
- Janus Henderson Group 7.19M sh · $490.00M · Q1 2026
- Wellington Management Group 4.13M sh · $336.74M · Q2 2026
- Geode Capital Management 2.21M sh · $180.09M · Q2 2026
- D. E. Shaw & Co 1.55M sh · $126.35M · Q2 2026
- Bank of America Corp 1.45M sh · $118.46M · Q2 2026
- Franklin Resources 1.03M sh · $83.80M · Q2 2026
- Invesco Ltd 941.58K sh · $76.80M · Q2 2026
- Northern Trust Corp 880.03K sh · $71.78M · Q2 2026
- Charles Schwab Investment Management 790.11K sh · $64.45M · Q2 2026
- Renaissance Technologies 723.50K sh · $59.02M · Q2 2026